Core Molding Technologies to Present and Host 1×1 Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26, 2025 GlobeNewswire August 12, 2025 COLUMBUS, Ohio, Aug. 12, 2025 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural […]

Elicio Therapeutics Announces Publication of ELI-002 Updated AMPLIFY-201 Phase 1 Follow-up Data in Nature Medicine for Minimal Residual Disease (“MRD”) Positive, Adjuvant-Stage Patients GlobeNewswire August 12, 2025 At extended median follow-up of 19.7 months, median overall survival (“OS”) increased from 16.33 to 28.94 months Clinical efficacy correlated with the magnitude of T cell responses specific

SimpleTherapy Ranks No. 1234 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies Debuts at No. 3 among Fresno-based companies and No. 127 in Healthcare & Medical GlobeNewswire August 12, 2025 FRESNO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) — SimpleTherapy, a leading omnichannel care provider of musculoskeletal (MSK) and behavioral health care solutions,

57 Confluent Health Physical and Occupational Therapists Receive Board-Certified Clinical Specialist Credential Certification Reflects Highest Level of Advanced Clinical Practice in Musculoskeletal Care GlobeNewswire August 12, 2025 LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) — Fifty-seven Physical and Occupational Therapists from Confluent Health's Partner Brands have achieved nationally recognized board certifications, a prestigious milestone that

Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update Continued advancement of SIL204 preclinical program with strong efficacy data across multiple KRAS-driven cancer types; company strengthened financial position and maintains progress toward clinical trials GlobeNewswire August 12, 2025 GRAND CAYMAN, Cayman Islands, Aug. 12, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ:

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment GlobeNewswire August 12, 2025 U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett's esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart(TM) test validation (>95% technical success) and, together with BE-Smart's demonstrated compatibility

AIBotics, Inc. Issues Mid-Year Shareholder Update Highlighting Corporate Progress, Technology Development, and Strategic Roadmap for Agentic AI Integration AIBotics in negotiations for a pilot program with a China-based global leader in commercial service robots designed to interact with people and collaborate with other robots GlobeNewswire August 12, 2025 MIAMI, Aug. 12, 2025 (GLOBE NEWSWIRE) —

Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments GlobeNewswire August 12, 2025 WILMETTE, Ill., Aug. 12, 2025 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinicalâ€stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today announced second quarter 2025 financial results and

Autoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets(TM). GlobeNewswire August 12, 2025 Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) — The global autoinjectors market, valued at US$1.08 billion in 2023, stood at US$1.40 billion in 2024 and is projected to advance at

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — T-RIZE Group, a Global fintech company specializing in institutional-grade tokenization, has officially listed its native utility token, $RIZE, on the Revolut App. The listing brings $RIZE to one of the world's most widely adopted financial platforms, expanding secure and regulated access to tokenized real-world assets (RWAs) for